Skip to content

Clinical trials

Terminated Phase 1/2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1/2 Status: Terminated Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20073
20081
20091
20121
20142
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Astex Pharmaceuticals, Inc.1
Baylor College of Medicine1
Charite University, Berlin, Germany1
Everett Meyer1
Milton S. Hershey Medical Center1
Poitiers University Hospital1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
Sun Pharma Advanced Research Company Limited1
Teva Branded Pharmaceutical Products R&D, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Leukemia5
Leukemia, Myeloid, Acute5
Myelodysplastic Syndromes4
Blast Crisis2
Multiple Myeloma2
Hematologic Diseases1
Hodgkin Disease1
Leukemia, Lymphocytic, Chronic, B-Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.